Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT05268016. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2a Study to Assess the Efficacy and Safety of ME3183 Administered Orally in Subjects With Moderate to Severe Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the efficacy and safety of ME3183 administered orally for moderate to severe plaque psoriasis in adults.
Study identification
- NCT ID
- NCT05268016
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 132 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 23, 2022
- Primary completion
- May 30, 2023
- Completion
- May 30, 2023
- Last update posted
- Jun 26, 2024
2022 – 2023
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northwest Arkansas Clinical Trials Center | Rogers | Arkansas | 72758 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| Colorado Medical Research Center, Inc. | Denver | Colorado | 80210 | — |
| International Dermatology Research, INC | Miami | Florida | 33144 | — |
| Qualmedica Research, LLC | Evansville | Indiana | 47715 | — |
| Owensboro Dermatology Associates | Owensboro | Kentucky | 42303 | — |
| Shondra L. Smith, MD Dermatology & Advanced Aesthetics | Lake Charles | Louisiana | 70605 | — |
| Skin Search of Rochester, Inc. | Rochester | New York | 14623 | — |
| Tennessee Clinical Research Center | Nashville | Tennessee | 37215 | — |
| Studies in Dermatology, LLC | Cypress | Texas | 77433 | — |
| Dermatology Treatment and Research Center | Dallas | Texas | 75230 | — |
| Center for Clinical Studies LTD, LLP | Houston | Texas | 77004 | — |
| Dermatology Clinical Research Center of San Antonio | San Antonio | Texas | 78229 | — |
| Premier Clinical Research | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05268016, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 26, 2024 · Synced Sep 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05268016 live on ClinicalTrials.gov.